申请人:Boehm Charles Jeffrey
公开号:US20080051416A1
公开(公告)日:2008-02-28
The present invention is directed to novel compounds of formula (I):
or pharmaceutically acceptable derivatives thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
本发明涉及新的化合物公式(I)或其药学上可接受的衍生物,以及它们作为药物的用途,特别是作为p38激酶抑制剂。